These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 5298831)

  • 1. Rheumatic diseases and the alimentary tract.
    Hawkins CF
    Rep Rheum Dis; 1967 Feb; 27():1-2. PubMed ID: 5298831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dangerous complications of antirheumatic therapy].
    Scheibe O
    Ther Ggw; 1970 Oct; 109(10):1486 passim. PubMed ID: 5312485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Leg ulcerations and anti-inflammatory treatments].
    Nguyen-Morére MC
    Phlebologie; 1973; 26(1):41-5. PubMed ID: 4541966
    [No Abstract]   [Full Text] [Related]  

  • 4. [Practice of the treatment with anti-inflammatory agents in rheumatology].
    Laurent F
    Therapeutique; 1970 May; 46():47-8. PubMed ID: 5310589
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs.
    Bahrt KM; Korman LY; Nashel DJ
    Arch Intern Med; 1984 Nov; 144(11):2165-6. PubMed ID: 6333854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroduodenal lesions in rheumatoid arthritis, mesenchymopathies and other rheumatisms. Endoscopic study].
    Maggiolo P; Pfau J; Klinger J
    Rev Med Chil; 1982 Nov; 110(11):1066-70. PubMed ID: 6985163
    [No Abstract]   [Full Text] [Related]  

  • 7. [Incidence of undesirable side-effects in the course of controlled clinical experiments with non-steroid antirheumatic agents].
    Pavelka K; Vojtísek O; Kanková D
    Vnitr Lek; 1978 Mar; 24(3):260-9. PubMed ID: 347697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases].
    Fiegel G
    Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254
    [No Abstract]   [Full Text] [Related]  

  • 9. The gut and arthritis.
    Haslock I; Wright V
    Rheumatol Rehabil; 1974 May; 13(2):51-61. PubMed ID: 4602161
    [No Abstract]   [Full Text] [Related]  

  • 10. [Kidneys in rheumatic diseases].
    Akizuki M; Yoshida S
    Ryumachi; 1983 Feb; 23(1):59-70. PubMed ID: 6223385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Flufenamic acid: therapeutic activity and secondary effects].
    Schiavetti L
    Clin Ter; 1972 Feb; 60(4):359-65. PubMed ID: 4260117
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical data of relation of rheumatism to gastrointestinal tract diseases].
    STOIIA I
    Sov Med; 1958 Sep; 22(9):23-31. PubMed ID: 13615478
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early clinical experiments with a new synthetic anti-inflammatory agent].
    Annoni G
    Clin Ter; 1969 Jan; 48(1):9-51. PubMed ID: 5311536
    [No Abstract]   [Full Text] [Related]  

  • 14. [Individual tolerance of drugs for rheumatic diseases].
    Miehle W
    Fortschr Med; 1985 Dec; 103(47-48):1102-4. PubMed ID: 3878821
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiological manifestations of the rheumatic diseases.
    Cardoe N
    Practitioner; 1978 Jan; 220(1315):75-8. PubMed ID: 305043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled clinical testing of a new anti-inflammatory agent].
    Malerba F; Barbi GL
    Clin Ter; 1969 Apr; 49(1):63-7. PubMed ID: 4930402
    [No Abstract]   [Full Text] [Related]  

  • 17. Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry.
    Falcini F; Trapani S; Ermini M; Bartolozzi G
    Pediatrics; 1995 Feb; 95(2):318. PubMed ID: 7838659
    [No Abstract]   [Full Text] [Related]  

  • 18. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs and a general population referred for endoscopy.
    Collins AJ; Davies J; Dixon SA
    Br J Rheumatol; 1986 Feb; 25(1):50-3. PubMed ID: 3484649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of rheumatic disease using a new antirheumatic drug].
    Weigel H
    Z Allgemeinmed; 1974 Nov; 50(33):1527-31. PubMed ID: 4549149
    [No Abstract]   [Full Text] [Related]  

  • 20. [Findings on the causes and mechanisms in the development of undesirable effects of non-steroidal anti-rheumatic agents and their incidence in controlled clinical trials].
    Pavelka K; Vojtísek D; Kañkova D; Perlík F; Pelísková Z
    Fysiatr Revmatol Vestn; 1982 Jan; 60(1):1-10. PubMed ID: 7040188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.